The short-term use of nicotine replacement therapy among smokers hospitalized for CHD did not affect rates of mortality, length of stay or 1-month readmission, suggesting it is a safe treatment option, according to a study published in the Journal of the American Heart Association.
“For years, clinicians have wondered about the safety of nicotine replacement therapy among smokers who are having a heart attack,” Quinn R. Pack, MD, MSc, preventive cardiologist and medical director of cardiac rehabilitation and wellness at the University of Massachusetts Medical School – Baystate, told Cardiology Today. “While prior studies have shown that nicotine replacement therapy is safe as an outpatient and after a hospitalization, our study is the first to show that nicotine replacement therapy has no apparent safety problems when used within the first 2 days of a heart attack, heart stenting procedure or coronary artery bypass surgery.”
This activity is supported by educational funding provided by Amarin Pharma Inc., Amgen, and Quest Diagnostics.
European Society of Cardiology Congress
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.